About Crystal Pharma
Gadea Pharmaceutical Group's Crystal Pharma division was purchased by AMRI in 2015. Crystal is Gadea's API business and manufactures a wide portfolio of APIs including high potency hormones and sterile steroids. In addition to contract manufacturing, Crystal also provides custom synthesis, specializing in complex molecules.
Gadea’s parenteral business, located in Leon, Spain, is focused on differential technologies, such as pre-filled syringes, suspensions, special particle size and an area for highly active products. The integration with Crystal Pharma’s sterile crystalized APIs, is paramount for the development of aseptic suspensions. Services include freeze drying of bulk APIs and vials; aseptic filling for vials, pre-filled syringes, eye-drop vials, and mono-dose; and handles highly active products with capabilities for API freeze drying, vial filling and prefilled syringes.